Formulation of three nitrosoureas for intravenous use.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002330:Carmustine / Q000008:administration & dosage / Q000627:therapeutic use*; D003510:Cyclohexanes / Q000008:administration & dosage / Q000627:therapeutic use; D004285:Dogs; D004655:Emulsions; D000431:Ethanol; D005223:Fats; D000882:Haplorhini; D007275:Injections, Intravenous; D007939:Leukemia L1210 / Q000188:drug therapy; D051379:Mice; D009607:Nitrosourea Compounds / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D012995:Solubility; D014867:Water
D000970:Antineoplastic Agents; D003510:Cyclohexanes; D004655:Emulsions; D005223:Fats; D009607:Nitrosourea Compounds; D014867:Water; D000431:Ethanol; D002330:Carmustine